Wen‐Hui Weng

1.1k total citations
49 papers, 695 citations indexed

About

Wen‐Hui Weng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wen‐Hui Weng has authored 49 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Wen‐Hui Weng's work include Advanced biosensing and bioanalysis techniques (8 papers), MicroRNA in disease regulation (7 papers) and Sarcoma Diagnosis and Treatment (6 papers). Wen‐Hui Weng is often cited by papers focused on Advanced biosensing and bioanalysis techniques (8 papers), MicroRNA in disease regulation (7 papers) and Sarcoma Diagnosis and Treatment (6 papers). Wen‐Hui Weng collaborates with scholars based in Taiwan, Sweden and United States. Wen‐Hui Weng's co-authors include See‐Tong Pang, Catharina Larsson, Jan Åhlén, Weng‐Onn Lui, Cheng‐Keng Chuang, Tung-Ming Pan, Hsi‐Hsien Hsu, Johan Wejde, Leonard Girnita and Olle Larsson and has published in prestigious journals such as Advanced Materials, Nano Letters and PLoS ONE.

In The Last Decade

Wen‐Hui Weng

48 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Hui Weng Taiwan 17 299 133 130 123 96 49 695
Minghua Ge China 15 270 0.9× 112 0.8× 112 0.9× 186 1.5× 84 0.9× 51 734
Xun Bao United States 16 503 1.7× 213 1.6× 187 1.4× 299 2.4× 58 0.6× 42 953
Álmos Klekner Hungary 20 389 1.3× 182 1.4× 89 0.7× 127 1.0× 91 0.9× 59 891
Edoardo Lazzarini Italy 21 442 1.5× 112 0.8× 71 0.5× 135 1.1× 117 1.2× 33 984
Misu Lee South Korea 18 417 1.4× 194 1.5× 56 0.4× 177 1.4× 93 1.0× 59 961
Chengzhan Zhu China 14 332 1.1× 163 1.2× 135 1.0× 166 1.3× 156 1.6× 44 766
Jialing Yuan China 14 520 1.7× 203 1.5× 143 1.1× 292 2.4× 38 0.4× 26 833
Jingwei Yu China 18 349 1.2× 108 0.8× 88 0.7× 280 2.3× 57 0.6× 69 990
Liyun Shen China 13 249 0.8× 141 1.1× 77 0.6× 179 1.5× 38 0.4× 30 756
Ming Yu China 15 279 0.9× 193 1.5× 73 0.6× 192 1.6× 40 0.4× 54 644

Countries citing papers authored by Wen‐Hui Weng

Since Specialization
Citations

This map shows the geographic impact of Wen‐Hui Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Hui Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Hui Weng more than expected).

Fields of papers citing papers by Wen‐Hui Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Hui Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Hui Weng. The network helps show where Wen‐Hui Weng may publish in the future.

Co-authorship network of co-authors of Wen‐Hui Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Hui Weng. A scholar is included among the top collaborators of Wen‐Hui Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Hui Weng. Wen‐Hui Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pang, See‐Tong, Emelie Berglund, I‐Hung Shao, et al.. (2025). First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer. BJUI Compass. 6(6). e70026–e70026. 1 indexed citations
2.
Huang, Kai‐Yuan, Zhiqiang Yang, Wen‐Hui Weng, et al.. (2025). Bioinspired Engineering of Programmable Proton-Coupled Electron Transfer in Gold Nanoclusters. Nano Letters. 25(47). 16764–16771.
3.
Weng, Wen‐Hui, et al.. (2025). Hsa-miRNA-16-5p Of Urinary Exosomes A Reliable Biosignature Effective For Prostate Cancer Screening. International Journal of Nanomedicine. Volume 20. 9291–9300. 1 indexed citations
4.
Pang, See‐Tong, Jasmine Lim, Yichun Zhang, et al.. (2024). Urinary MicroRNA-21 for Prostate Cancer Detection Using a Silver Nanoparticle Sensor: A Promising Diagnostic Tool. Biosensors. 14(12). 599–599. 1 indexed citations
5.
Yu, Kai‐Jie, Po‐Hung Lin, Aron Y. Joon, et al.. (2023). Should Patients with Renal Cell Carcinoma and Pathological Nodal Invasion Be Classified As Having Stage IV Disease?. Annals of Surgical Oncology. 30(8). 5286–5294. 2 indexed citations
6.
Weng, Wen‐Hui, et al.. (2022). Micro-RNA378a-3p Induces Apoptosis in Sarcomatoid Renal Cell Carcinoma and Regulates POLR2A and RUNX2 Expression. Anticancer Research. 42(2). 811–825. 1 indexed citations
7.
Yeh, Chun‐Nan, Yu‐Chan Chang, Ren‐Chin Wu, et al.. (2018). Over‐expression of TNNI3K is associated with early‐stage carcinogenesis of cholangiocarcinoma. Molecular Carcinogenesis. 58(2). 270–278. 8 indexed citations
8.
Weng, Wen‐Hui, et al.. (2018). Real-time circulating tumor cells detection via highly sensitive needle-like cytosensor-demonstrated by a blood flow simulation. Biosensors and Bioelectronics. 116. 51–59. 16 indexed citations
9.
Weng, Wen‐Hui, et al.. (2015). Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression. Oncology Reports. 35(1). 107–116. 28 indexed citations
10.
Kuo, Sung‐Hsin, Wen‐Hui Weng, Ping‐Ning Hsu, et al.. (2011). Establishment of a novel MALT lymphoma cell line, ma‐1, from a patient with t(14;18)(q32;q21)‐positive Helicobacter Pylori‐Independent Gastric MALT Lymphoma. Genes Chromosomes and Cancer. 50(11). 908–921. 6 indexed citations
11.
Weng, Wen‐Hui. (2011). Phosphorylated T567 ezrin is associated with merlin expression in KIT-mutant gastrointestinal stromal tumors. Molecular Medicine Reports. 5(1). 17–21. 3 indexed citations
12.
Hashemi, Jamileh, Claire Worrall, Daiana Vasilcanu, et al.. (2011). Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP). PLoS ONE. 6(3). e14757–e14757. 16 indexed citations
13.
Tai, Dar‐In, et al.. (2011). New sarcomatoid cancer cell line SAR-HCV established from a hepatitis C virus-related liver tumour lesion.. PubMed. 31(1). 129–37. 3 indexed citations
14.
Wu, Ching‐Fang, See‐Tong Pang, Jia‐Jen Shee, et al.. (2010). Identification of genetic alterations in upper urinary tract urothelial carcinoma in end‐stage renal disease patients. Genes Chromosomes and Cancer. 49(10). 928–934. 13 indexed citations
15.
Yeh, Chun‐Nan, et al.. (2009). Expression of ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinoma. BMC Cancer. 9(1). 233–233. 24 indexed citations
16.
Pang, See‐Tong, et al.. (2008). Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glucose in human prostate carcinoma cells. Journal of Molecular Endocrinology. 42(3). 205–214. 20 indexed citations
17.
Weng, Wen‐Hui, Alexander Claviez, Matthias Krams, et al.. (2006). A 10-year-old girl with bifocal synovial sarcoma. The Lancet Oncology. 7(7). 605–607. 1 indexed citations
18.
Åhlén, Jan, Johan Wejde, Otte Brosjö, et al.. (2005). Insulin-Like Growth Factor Type 1 Receptor Expression Correlates to Good Prognosis in Highly Malignant Soft Tissue Sarcoma. Clinical Cancer Research. 11(1). 206–216. 57 indexed citations
19.
Pang, See‐Tong, Wen‐Hui Weng, Amilcar Flores‐Morales, et al.. (2005). Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer. The Prostate. 66(2). 157–172. 16 indexed citations
20.
Weng, Wen‐Hui, Johan Wejde, Jan Åhlén, et al.. (2004). Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH. Cancer Genetics and Cytogenetics. 150(1). 27–32. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minghua Ge Breakdown of academic impact, for papers by Xun Bao Breakdown of academic impact, for papers by Álmos Klekner Breakdown of academic impact, for papers by Edoardo Lazzarini Breakdown of academic impact, for papers by Misu Lee Breakdown of academic impact, for papers by Chengzhan Zhu Breakdown of academic impact, for papers by Jialing Yuan Breakdown of academic impact, for papers by Jingwei Yu Breakdown of academic impact, for papers by Liyun Shen Breakdown of academic impact, for papers by Ming Yu
Rankless by CCL
2026